STSS

Sharps Technology

--(--)

Market Open: --

--(--)

Post-Market: --

Signals Analysis

Buy signal 1

Sell signal 2

EPS Beats Expectation

Price Hits New Low

Price Hits 52-week low

Key Stats

--DAY`S RANGE--

--52 WK RANGE--

Open

Prev.Close

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

Low

52 Week High

52 Week Low

About STSS

Sharps Technology, Inc.

An innovative medical device company that offers smart safety syringe products

Industry

Healthcare Equipment and Supplies

Established Date

12/16/2017

Listing Date

04/14/2022

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

sharpstechnology.com

Security Type

Common stock

Office address

105 Maxess Road, Ste. 124, Melville, New York 11747

Business

Introduction

Sharps Technology, Inc., was incorporated under the laws of Wyoming on December 16, 2017. On March 22, 2022, the Company was re-registered as a Nevada corporation pursuant to the merger into a newly formed Nevada corporation. The company, a medical device company that has designed and patented various safety syringes, seeks to commercialize them. The company was incorporated to purchase, develop and commercialize intellectual property, resulting in a range of smart safety syringe products. The company's safety syringes, referring to Sharps Provensa, feature ultra-low waste and passive safety features that the company believes will provide a competitive advantage over syringes. Sharps Provensa is a patented and FDA-approved safety syringe that addresses important needs in the global healthcare market.

Company Financials

EPS

STSS has released its 2023 Q3 earnings. EPS was reported at -0.17, versus the expected -0.09, missing expectations. The chart below visualizes how STSS has performed over recent quarters, highlighting trends in earnings surprises.